Harvard has investigated work from the lab of a cancer researcher at Beth Israel Deaconess Medical Center that has been under scrutiny on PubPeer for more than five years. Questions about the output of the lab, run by James W. Mier, began appearing on PubPeer in 2014, with comments about images that looked manipulated. The … Continue reading Cancer lab at Harvard subject of inquiry
Carlo Croce, a prolific cancer researcher at The Ohio State University in Columbus who was the subject of a front page story in The New York Times last year about allegations of misconduct against him, has had most of a lawsuit he filed against the newspaper thrown out. As first reported by Courthouse News Service, … Continue reading Judge dismisses most of Carlo Croce’s libel case against the New York Times
A professor specializing in the health of children and pregnant women has left her post at the University of Glasgow, and issued three retractions in recent months. All three notices — issued by PLOS ONE — mention an investigation at the university, which found signs of data manipulation and falsification. Fiona Lyall, the last author … Continue reading Glasgow professor leaves post amidst multiple retractions
A cancer researcher based at The Ohio State University has retracted five papers from one journal, citing concerns about figures. The notices for all five papers state the Journal of Biological Chemistry raised questions about some figures, and the authors were not able to supply raw data in all instances. Four of the notices say … Continue reading Cancer biologist retracts five papers
A pharmacology journal has retracted a 2011 paper after concluding images in three figures had been manipulated. According to the British Journal of Pharmacology, four of the five authors claim they played no role in the manipulation. There is no comment from the remaining author, first author Ian Morecroft, a research associate at the University of … Continue reading Three figures in blood pressure paper were manipulated, says journal
The week at Retraction Watch featured a lawsuit threat following criticism of a popular education program, and the new editor of PLOS ONE’s explanation of why submissions are down. Here’s what was happening elsewhere:
Today isn’t a great day for Carlo Croce, chair of the department of cancer biology and genetics at The Ohio State University (OSU). The New York Times has a lengthy article detailing the misconduct accusations that have swirled around Croce for years. We’ve covered many, but The Gray Lady obtained documents that show there have been … Continue reading Cancer researcher has dodged accusations for decades (and has a new correction)
On Tuesday, lawyers representing both sides of the ongoing suit filed by a scientist against PubPeer commenters appeared in court, alleging their criticisms of his work cost him a new job at the University of Mississippi. In the case described as “FAZLUL SARKAR V JOHN DOE,” lawyers representing PubPeer, Sarkar, and the anonymous commenter at the heart of … Continue reading Sarkar vs. John Doe: What happened at this week’s hearing involving PubPeer
Consider this: Fragments of a PLOS ONE paper overlap with pieces of other publications. The authors used them without credit and without quotation marks. This sounds an awful lot like plagiarism — using PLOS‘s own standards, even. But the journal isn’t calling it plagiarism. They’ve labeled this an instance of “text overlap,” a spokesperson told us, based … Continue reading When does “overlap” become plagiarism? Here’s what PLOS ONE decided
Fazlul Sarkar has not had a good month: In the last few weeks, he has earned 13 retractions across four journals, the latest in the fallout from a string of legal cases that have pitted him against one of science publishing’s major players. Sarkar gained attention in 2014 when he sued anonymous commenters of PubPeer for defamation, and … Continue reading Meet the researcher with 13 retractions who’s trying to sue PubPeer commenters: Fazlul Sarkar